March 28, 2025

Novartis’ prostate cancer drug Pluvicto wins key FDA nod toward $5B-plus sales target – Fierce Pharma

March 28, 2025

New Surgical Technique Preserves Erectile Function In Prostate Cancer Patients – Watauga Democrat

March 28, 2025

FDA Approves Novartis’ Pluvicto for Early Use in Prostate Cancer Treatment – TipRanks

March 28, 2025

FDA Expands New Treatment for Prostate Cancer: Targets a Protein Called PSMA – Memorial Sloan Kettering Cancer Center

March 28, 2025

MHRA approves trofolastat for prostate cancer diagnostic imaging – Medical Device Network